ArticleHemaSphere2026

Preclinical evaluation of the ROR1-targeting antibody-drug conjugates zilovertamab vedotin and VLS-211 against B-cell ALL patient-derived xenografts.

Christopher M Smith et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.